Spectrum of Benign Bone Conditions on NaF-PET

Fluoride imaging with18 F (NaF-PET), although not a new technique, is becoming increasingly utilized for evaluation of skeletal metastatic disease using PET/CT. As its use becomes more widespread, a variety of nonmalignant bone disorders will be encountered by the interpreting physician. It is impor...

Full description

Saved in:
Bibliographic Details
Published in:Seminars in nuclear medicine 2017-07, Vol.47 (4), p.392-396
Main Authors: Rohren, Eric M., MD, PhD, Macapinlac, Homer A., MD
Format: Article
Language:English
Subjects:
Bone Diseases - diagnostic imaging
Fluorine Radioisotopes
Humans
Multimodal Imaging
Positron Emission Tomography Computed Tomography
Positron-Emission Tomography
Radiology
Sodium Fluoride
Tomography, X-Ray Computed
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Fluoride imaging with18 F (NaF-PET), although not a new technique, is becoming increasingly utilized for evaluation of skeletal metastatic disease using PET/CT. As its use becomes more widespread, a variety of nonmalignant bone disorders will be encountered by the interpreting physician. It is important, therefore, to recognize these nonmalignant conditions to avoid errors in interpretation. Beyond this, there is increasing evidence in the literature that NaF-PET/CT imaging may provide valuable information for the primary diagnosis of these nonmalignant conditions, and furthermore may provide insight into the underlying biology leading to management decisions. In this article, we review a spectrum of benign bone conditions that can be visualized on NaF-PET.
ISSN:0001-2998
1558-4623
DOI:10.1053/j.semnuclmed.2017.02.008